46
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy

, , , , , & show all
Pages 485-492 | Published online: 03 Mar 2014

References

  • BennettSRFolkJCBlodiCFKlugmanMFactors prognostic of visual outcome in patients with subretinal hemorrhageAm J Ophthalmol1990109133372297030
  • ChanWMLiuDTLaiTYLiHTongJPLamDSExtensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow upClin Experiment Ophthalmol200533661161816402954
  • AveryRLFekratSHawkinsBSBresslerNMNatural history of subfoveal subretinal hemorrhage in age-related macular degenerationRetina19961631831898789855
  • BerrocalMHLewisMLFlynnHWJrVariations in the clinical course of submacular hemorrhageAm J Ophthalmol199612244864938862044
  • SaitoKIijimaH[Visual prognosis and macular pathology in eyes with retinal macroaneurysms]Nippon Ganka Gakkai Zasshi19971012148151 Japanese9124095
  • IbanezHEWilliamsDFThomasMASurgical management of submacular hemorrhage. A series of 47 consecutive casesArch Ophthalmol1995113162697826295
  • ChenWLLiuJHLeeFLNatural course of submacular hemorrhageZhonghua Yi Xue Za Zhi (Taipei)199962526827710389281
  • HeriotWFuther experience in management of submacular hemorrhage with intravitreal tPAProceedings of the Update on Macular SurgerySan Francisco, CA, USAAmerican Academy of Ophthalmology1997
  • OhjiMSaitoYHayashiALewisJMTanoYPneumatic displacement of subretinal hemorrhage without tissue plasminogen activatorArch Ophthalmol199811610132613329790631
  • HassanASJohnsonMWSchneidermanTEManagement of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacementOphthalmology1999106101900190610519583
  • MizutaniTYasukawaTItoYPneumatic displacement of submacular hemorrhage with or without tissue plasminogen activatorGraefes Arch Clin Exp Ophthalmol201124981153115721445629
  • FangIMLinYCYangCHYangCMChenMSEffects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degenerationEye (Lond)200923239740617975562
  • RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging200536433133516156152
  • RichRMRosenfeldPJPuliafitoCAShort-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRetina200626549551116770255
  • BashshurZFBazarbachiASchakalAHaddadZAEl HaibiCPNoureddinBNIntravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degenerationAm J Ophthalmol200614211916815245
  • StifterEMichelsSPragerFIntravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhageAm J Ophthalmol2007144688689217916314
  • SacuSStifterEVecsei-MarlovitsPVManagement of extensive subfoveal haemorrhage secondary to neovascular age-related macular degenerationEye (Lond)20092361404141018756282
  • GuthoffRGuthoffTMeigenTGoebelWIntravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degenerationRetina2011311364020921929
  • CakirMCekicOYilmazOFPneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activatorEur J Ophthalmol201020356557120037915
  • JohnsonMWOlsenKRHernandezETissue plasminogen activator treatment of experimental subretinal hemorrhageRetina19911122502581925092
  • ChenCYHooperCChiuDChamberlainMKariaNHeriotWJManagement of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gasRetina200727332132817460587
  • ChawlaSMisraVKhemchandaniMPneumatic displacement and intravitreal bevacizumab: a new approach for management of submacular hemorrhage in choroidal neovascular membraneIndian J Ophthalmol200957215515719237795
  • HaslerPWla CourMVillumsenJPneumatic displacement and intravitreal bevacizumab in the management of subretinal haemorrhage caused by choroidal neovascularizationActa Ophthalmol Scand200785557757917559558
  • HuangJLiuXWuZXiaoHDustinLSaddaSMacular thickness measurements in normal eyes with time-domain and Fourier-domain optical coherence tomographyRetina200929798098719584656
  • KungY-HWuT-THongM-CSheuS-JIntravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhageJ Ocul Pharmacol Ther201026546947420925578
  • ShoKTakahashiKYamadaHPolypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristicsArch Ophthalmol2003121101392139614557174
  • MarukoIIidaTSaitoMNagayamaDSaitoKClinical characteristics of exudative age-related macular degeneration in Japanese patientsAm J Ophthalmol20071441152217509509
  • YoonJSLeeJLeeSCKohHJKimSSKwonOWPolypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhageYonsei Med J200748222523217461520
  • HesseLSchmidtJKrollPManagement of acute submacular hemorrhage using recombinant tissue plasminogen activator and gasGraefes Arch Clin Exp Ophthalmol1999237427327710208258
  • GomiFSawaMSakaguchiHEfficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathyBr J Ophthalmol2008921707317567661